Gene · 1241
Papers1,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oxoeicosanoid signaling mediates early antimicrobial defense in zebrafish. | Cell Rep | 2023 | 36640321 | PubTator, text mining | PubMed |
| Mandibulofacial dysostosis with alopecia results from ETAR gain-of-function mutations via allosteric effects on ligand binding. | J Clin Invest | 2023 | 36637912 | PubTator, text mining | PubMed |
| High-density lipoproteins mediate small RNA intercellular communication between dendritic cells and macrophages. | J Lipid Res | 2023 | 36626966 | PubTator, text mining | PubMed |
| Network Pharmacological Analysis on the Herbal Combinations for Mitigating Inflammation in Respiratory Tracts and Experimental Evaluation. | Healthcare (Basel) | 2023 | 36611603 | PubTator, text mining | PubMed |
| Clinicopathological Significances and Prognostic Value of PPFIA4 in Colorectal Cancer. | J Cancer | 2023 | 36605492 | PubTator, text mining | PubMed |
| Soluble epoxide hydrolase inhibition enhances production of specialized pro-resolving lipid mediator and promotes macrophage plasticity. | Br J Pharmacol | 2023 | 36508312 | PubTator, text mining | PubMed |
| Targeting UGCG Overcomes Resistance to Lysosomal Autophagy Inhibition. | Cancer Discov | 2023 | 36331284 | PubTator, text mining | PubMed |
| Untargeted serum metabolomic analysis reveals a role for purinergic signaling in FPIES. | J Allergy Clin Immunol | 2023 | 36306938 | PubTator, text mining | PubMed |
| Neutrophils in the periodontium: Interactions with pathogens and roles in tissue homeostasis and inflammation. | Immunol Rev | 2023 | 36271881 | PubTator, text mining | PubMed |
| Specialized Pro-Resolving Mediators as Resolution Pharmacology for the Control of Pain and Itch. | Annu Rev Pharmacol Toxicol | 2023 | 36100219 | PubTator, text mining | PubMed |
| Epigenetic modifications in chronic rhinosinusitis with and without nasal polyps. | Front Genet | 2022 | 36699454 | PubTator, text mining | PubMed |
| COVID-19 Pathology Sheds Further Light on Balance between Neutrophil Proteases and Their Inhibitors. | Biomolecules | 2022 | 36671467 | PubTator, text mining | PubMed |
| Exploring the Potential Mechanism of Artemisinin and Its Derivatives in the Treatment of Osteoporosis Based on Network Pharmacology and Molecular Docking. | Comput Math Methods Med | 2022 | 36590764 | PubTator, text mining | PubMed |
| Revisiting the immune landscape post spinal cord injury: More than black and white. | Front Aging Neurosci | 2022 | 36570540 | PubTator, text mining | PubMed |
| Integrative transcriptomic analysis in human and mouse model of anaphylaxis identifies gene signatures associated with cell movement, migration and neuroinflammatory signalling. | Front Immunol | 2022 | 36569939 | PubTator, text mining | PubMed |
| DNA Methylation Analysis Reveals Distinct Patterns in Satellite Cell-Derived Myogenic Progenitor Cells of Subjects with Spastic Cerebral Palsy. | J Pers Med | 2022 | 36556199 | PubTator, text mining | PubMed |
| Sputum from patients with primary ciliary dyskinesia contains high numbers of dysfunctional neutrophils and inhibits efferocytosis. | Respir Res | 2022 | 36528664 | PubTator, text mining | PubMed |
| Roles of Resolvins in Chronic Inflammatory Response. | Int J Mol Sci | 2022 | 36499209 | PubTator, text mining | PubMed |
Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer. | Cancers (Basel) | 2022 | 36497496 | PubTator, text mining | PubMed |
| The Expression Pattern of Adhesion G Protein-Coupled Receptor F5 Is Related to Cell Adhesion and Metastatic Pathways in Colorectal Cancer-Comprehensive Study Based on In Silico Analysis. | Cells | 2022 | 36497132 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1241/papers?page=9